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Chronic wasting disease (CWD) of deer and elk is a 
widespread health concern because its potential for cross-
species transmission is undetermined. CWD prevalence in 
wild elk is much lower than its prevalence in wild deer, and 
whether CWD-infected deer and elk differ in ability to infect 
other species is unknown. Because lymphoid tissues are 
important in the pathogenesis of some transmissible spon-
giform encephalopathies such as sheep scrapie, we investi-
gated whether CWD-affected elk and deer differ in distribu-
tion or quantity of disease-associated prion protein (PrPres) 
in lymphoid tissues. Immunoblot quantiﬁ   cation of PrPres 
from tonsil and retropharyngeal lymph nodes showed much 
higher levels of PrPres in deer than in elk. This difference 
correlated with the natural prevalence of CWD in these spe-
cies and suggested that CWD-infected deer may be more 
likely than elk to transmit the disease to other cervids and 
have a greater potential to transmit CWD to noncervids.
C
hronic wasting disease (CWD) is an emerging in-
fectious disease ﬁ  rst recognized in the 1960s. It is a 
member of the transmissible spongiform encephalopathy 
(TSE) disease group that includes sheep scrapie, bovine 
spongiform encephalopathy (BSE), transmissible mink 
encephalopathy, and several human diseases, including 
kuru, Creutzfeldt-Jakob disease (CJD), and variant CJD 
(vCJD). Several heritable but extremely rare forms of TSE 
are found, most notably, Gerstmann-Straussler-Schienker 
syndrome (GSS) and fatal familial insomnia. CWD, like 
other TSE diseases, is characterized by the accumulation 
in neural tissues of an abnormal disease-associated prion 
protein designated PrPres (1), PrPSc (2), or PrPd (3). Most 
TSE researchers believe that PrPres is critical in disease 
pathogenesis, and some evidence suggests that PrPres may 
itself be the infectious agent (4).
As recently as 1997, CWD in the wild appeared to be 
conﬁ  ned to a few counties of northeast Colorado and south-
east Wyoming. Since then, new cases have been reported 
in wild deer from many additional states. The disease has 
recently emerged in captive elk and deer facilities scattered 
across the United States and Canada. Whether these new 
foci of infection resulted from contact with captive cervids 
or represent established foci of infection discovered by 
recent surveys is unknown. In disease-endemic areas, the 
prevalence of CWD in deer is variable but is often >5%. In 
contrast, the prevalence in wild elk is typically <1% (5,6). 
What factors account for different CWD prevalence in the 
wild between deer and elk are not known.
In some species, the infectious agent and PrPres ac-
cumulate in both lymphoid tissues and brain. The extent of 
lymphoid tissue involvement varies depending on the host 
and agent involved. In scrapie-infected sheep, lymph nodes 
and spleen are infected early and are directly involved in 
the kinetics of disease (7–9). Lymphoid tissues are likewise 
important in vCJD (10) in humans and also in some TSE 
mouse models (11–13). In other TSE diseases such as BSE 
and sporadic CJD, lymphoid tissues appear to play little or 
no essential role in disease pathogenesis (14,15). Knowing 
the extent of lymphoid tissue involvement in deer and elk 
might provide clues regarding modes of natural transmis-
sion in these species or the potential for transmission to 
other species.
PrPres in lymphoid tissues of deer (16) and elk (17) 
has been primarily detected by using immunohistochemical 
(IHC) techniques. However, with these techniques, quanti-
ﬁ  cation and glycoform analysis of PrPres are not possible. 
We were interested in determining whether PrPres found in 
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lymphoid tissues of deer differs from PrPres found in lym-
phoid tissues of elk in quantity, distribution, or structural 
features. Immunoblot techniques enabled us to study these 
questions.
Surveys of CWD-infected deer and elk based on IHC 
or ELISA analysis of brain or retropharyngeal lymph nodes 
(RPLNs) have not shown differences between the 2 spe-
cies that explain why CWD prevalence differs in natural 
settings (18,19). In our study, we sought to identify poten-
tial differences in biochemical characteristics of PrPres to 
explain the prevalence differences between the 2 species. 
We found that lymphoid tissues of CWD-infected deer had 
much greater quantities of PrPres than were detected in 
similar samples from elk. Furthermore, we found a wider 
distribution and higher incidence of positive lymphoid tis-
sues in deer. These differences might account for the dispar-
ity in the reported prevalence of CWD in the wild between 
deer and elk. Our results also support previous observations 
that suggested CWD surveillance programs based on IHC 
detection of PrPres in lymphoid tissues alone may not be 
appropriate for elk (5,18).
Materials and Methods
Tissues 
Brain, tonsil, spleen, and selected lymph nodes, includ-
ing RPLNs, prescapular, submandibular, superﬁ  cial cervi-
cal, mesenteric, popliteal, and ileocecal-colic lymph nodes, 
were obtained from 10 CWD-infected elk and 15 CWD-
infected deer (12 mule deer and 3 white-tailed deer). Elk 
were derived from game farms or research facilities where 
they became infected by contact with CWD-infected elk, a 
contaminated environment, or oral inoculation. All of the 
elk used in this study had deﬁ  nite clinical cases when they 
were euthanized. The deer used for PrPres quantiﬁ  cation all 
had conﬁ  rmed clinical cases and were from research facili-
ties where they became infected by contact with infected 
animals. Three of the mule deer, included in Table 1, were 
harvested by Colorado Division of Wildlife or Wyoming 
Department of Game and Fish personnel. Tissues from 
wild uninfected deer and elk were obtained from Montana 
Department of Fish, Wildlife and Parks. More than 4,000 
wild deer and elk from Montana have been tested for CWD 
with no positives found.
PrPres Puriﬁ  cation 
Twenty percent tissue homogenates of brain, tonsil, 
lymph nodes, or spleen from CWD-infected or uninfected 
deer and elk were made in 10 mmol/L Tris-HCl, pH 7.4, 5 
mmol/L MgCl2 by using either disposable Konex micro-
centrifuge tubes (Kimble/Kontes, Vineland, NJ, USA) and 
matched pestles (brain) or an omni tissue homogenizer 
(tonsil, spleen, and lymph nodes); 75%–90% of the total 
tissue mass of respective lymph nodes or tonsil was ho-
mogenized. Two-hundred–milligram aliquots of the total 
homogenate were processed further to concentrate PrPres 
by using ultracentifugation and proteinase K digestion as 
described (20).
Immunoblotting 
Protein gel electrophoresis and immunoblotting were 
done as previously described (21,22) by using polyclonal 
antibody R35 (23) or monoclonal antibody L-42 (R-Bio-
pharm AG, Darmstadt, Germany). L-42 reacts with PrPres 
from several species, including deer and elk, and has been 
well characterized (24). Blots were developed by using ei-
ther an enhanced chemiluminescence (ECL) or enhanced 
chemiﬂ  uorescence (ECF) system, according to the manu-
facturer’s instructions (Amersham-Pharmacia, Piscataway, 
NJ, USA). ECL blots were exposed to ﬁ  lm to visualize pro-
teins. ECF blots were scanned by using a STORM ﬂ  uores-
cent detection system (Amersham-Pharmacia) as described 
previously (25).
PNGaseF Digestion 
Reagents and enzymes for PNGaseF treatment were pur-
chased from New England BioLabs (Beverly, MA, USA). Re-
action conditions were as recommended by the manufacturer 
except that denaturing of 1- to 30-mg tissue equivalents was 
done in a total volume of 20 μL sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis sample buffer. Each sample 
was digested by using 2,500 U PNGaseF and incubated 
overnight at 37°C. Samples were frozen at −20°C until they 
were analyzed by immunoblotting.
Results
Quantiﬁ  cation of PrPres in Brain, Tonsil, and RPLNs
Tissues from 10 CWD-affected elk and 15 CWD-af-
fected deer were analyzed in this study. All 10 of the elk 
had advanced clinical CWD when euthanized. The deer 
Table 1. PrPres detection by immunoblot in brain and lymphoid 
tissues of elk and deer* 
Species Brain Spleen Tonsil
Lymph 
node
Elk 10/10 2/10 4/9 5/10
Mule deer  12/12 2/10 9/10 12/12
White-tailed deer  3/3 1/3 2/3 3/3
*PrPres, disease-associated prion protein. Values indicate the number of 
animals with PrPres detected (numerator) over the number analyzed 
(denominator). If any PrPres was detected in a given tissue, it was 
considered positive for the purpose of this table. If even a single lymph 
node from a given animal was positive, the animal was scored as positive 
for that tissue. This table does not consider quantitative variation in the 
amount of PrPres in tissues of elk compared to deer. The denominators 
vary because not every tissue was available from every animal. Brain, 
tonsil, and lymph nodes of elk did not differ significantly from mule deer 
(Fisher exact test). RESEARCH
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represented various stages of clinical disease. Detailed data 
showing PrPres glycoform proﬁ  les and quantiﬁ  cation of 
PrPres are shown for 5 of the elk and 6 of the deer (Figure 
1). Each of the elk brains gave a very strong PrPres signal 
when 2-mg brain equivalents were analyzed. Deer brain 
PrPres was more variable, and 20 mg of brain equivalent 
was analyzed (Figure 1). The relative amount of PrPres in 
each sample was determined by comparing the PrPres sig-
nal to a standard control. The standard control for each blot 
was RPLN from one of the CWD-infected mule deer in the 
study (labeled C in each blot, Figure 1). Relative PrPres 
amounts were determined by using a phosphor-imager 
and Image Quant software (Storm, Molecular Dynamics, 
Sunnyvale, CA, USA). The average amount of PrPres in 
elk brain was consistently higher than the amount in deer 
brain (Figure 2). The lower amounts of PrPres in deer brain 
than in elk brain likely reﬂ  ects the more variable and earlier 
clinical status of the deer that were analyzed.
Diagnosis of CWD is often based on detection of 
PrPres in tonsil tissue by using ELISA and IHC analysis. 
Therefore, we also analyzed tonsil tissue, but because we 
were interested in quantitative issues we used immunoblot 
technology.
No PrPres was observed in tonsil from 2 of the elk 
(Figure 1B), and only a small amount was detected in ton-
sil from the other 3 elk (Figures 1B, 2B). PrPres in the 3 
tonsil specimens that did give a signal averaged 4% of the 
control’s signal. In contrast, tonsil from 5 of the 6 CWD-
affected deer gave a strong PrPres signal (Figure 1B), aver-
aging 109% of the reference control’s signal. However, the 
tonsil of the remaining deer (#4, Figures 1B, 2B) gave no 
PrPres signal on immunoblot.
PrPres quantities in RPLNs from elk were also low. 
RPLN from 1 elk was negative (#4, Figure 1C), while weak 
reactions were seen for RPLNs from the other 4 elk at 2%, 
2%, 5.1%, and 13% of the control, respectively (Figures 
1C, 2C). RPLNs from the deer were much stronger. RPLNs 
from all 6 deer were positive and ranged from 3.4% to 100% 
of that of the control (Figures 1C, 2C). One of the deer (#4, 
Figure 1B, C) had no PrPres detected in tonsil and very 
little in RPLN, even though the reaction from the brain of 
this deer was strong. Tonsils and RPLNs from 5 additional 
CWD-infected elk and 9 additional CWD-infected deer, 
including 3 white-tailed deer, showed PrPres in amounts 
similar to those of most elk and deer shown in Figures 1 
and 2, but detailed quantiﬁ  cation was not carried out on 
these samples. The combined data for all elk and deer show 
tonsil and RPLN specimens to be consistently PrPres posi-
tive by immunoblot in deer but positive less frequently in 
elk (Table 1).
We also sought to determine whether all of the nodes 
from individual deer contain similar levels of PrPres. Con-
siderable variation was observed. In some deer, every node 
that was tested was PrPres positive, but more frequently 
only 1 or 2 nodes were positive. Furthermore, the inten-
sity of the PrPres signals varied from node to node. In 
most deer, RPLN gave the strongest PrPres signal, but in 
other deer the prescapular or submandibular nodes were 
best (Figure 3). The mesenteric node was often positive, 
but generally gave a weak PrPres signal (Figure 3, lane 7). 
Thus, analysis of a single lymph node other than the RPLN 
by immunoblot would likely result in some CWD-positive 
deer being undetected.
The spleen has been shown to inﬂ  uence disease patho-
genesis in both sheep and mouse models of TSE disease 
(7,12,13,26). Therefore, we also sought to quantify the 
amount of PrPres in elk and deer spleen. However, all of 
the animals gave very weak or no PrPres signals in spleen 
(Table 1) (blots not shown). Thus CWD-affected elk and 
deer differed from scrapie-affected sheep, in which the 
spleen routinely gives a strong PrPres signal.
Figure 1. Immunoblot analysis of PrPres from chronic wasting 
disease (CWD)–affected elk and deer brain, tonsil, and 
retropharyngeal lymph node (RPLN). Panel A shows the PrPres 
signal from 2-mg equivalents of elk brain or 20-mg equivalents of 
deer brain. Individual animals are identiﬁ   ed as 1–5 (elk) or 1–6 
(deer). C denotes the reference control to which all other samples 
are compared and consists of 20-mg equivalents of retropharyngeal 
lymph node (RPLN) from a CWD–affected mule deer. Aliquots of 
this same control are included on all blots shown in panels B and C. 
Lanes labeled U in panels A, B, and C contain 20-mg equivalents 
of the respective tissue from uninfected elk or deer.  No PrPres 
bands were detected when tissues from uninfected deer or elk 
were analyzed. In panels B and C, 20-mg equivalents of tonsil or 
RPLN were used. PrPres was obtained as described in Materials 
and Methods and the blots developed by using antibody L42 at 
a 0.04 μg/mL dilution and standard enhanced chemiﬂ  uorescence 
processing. Approximate molecular weights in kd are indicated on 
the left side of the panels. Chronic Wasting Disease in Deer and Elk
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PrPres Glycoform Patterns in Lymphoid Tissues of 
CWD-infected Elk and Deer
PrPres glycoform patterns have been used to deﬁ  ne 
TSE strains and have been studied extensively in deer and 
elk brain (23). Therefore, we evaluated the PrPres glyco-
form patterns of lymphoid tissues of CWD-infected deer 
and elk to identify proﬁ  les that might differentiate deer 
from elk. The glycoform proﬁ  le in deer tonsil and lymph 
node were similar to that of the proﬁ  le in deer brain (Figure 
4). Likewise, there was no convincing difference in the pat-
tern of PrPres found in deer and elk brains (Figure 1). A 
meaningful comparison of glycoform patterns between elk 
and deer tonsil and lymph nodes was not possible because 
none of the elk lymphoid organs gave a sufﬁ  ciently strong 
PrPres signal.
Because PrPres band differences can be due both to dif-
fering glycosylation and different sites of proteinase cleav-
age, we treated samples of various tissues with PNGaseF 
to remove carbohydrates and thus show any differences 
due to proteolytic cleavages. Such differences in the PrPres 
structural core might provide evidence for the existence 
of different CWD strains as seen before in other TSE dis-
eases (27–29). However, no differences were detected in 
PNGaseF-digested PrPres from elk and deer brain (Figure 
4). Thus, both glycoform proﬁ  les and PNGaseF analysis 
indicated that PrPres from elk and deer were similar.
Discussion
We found marked differences in the quantity of PrPres 
in tonsil and lymph nodes of CWD-infected elk versus deer 
Figure 2. Quantiﬁ  cation of disease-associated prion protein (PrPres) 
in brain, tonsil, and retropharyngeal lymph node (RPLN) from 
chronic wasting disease–affected elk and deer. The relative amount 
of PrPres in each lane of Figure 1 is shown relative to a common 
control described in the Figure 1 legend. A split scale is shown for 
elk brain because the PrPres signal from each elk brain was strong 
enough with 2-mg equivalents of tissue to obscure the protein 
patterns on the gel. Twenty-milligram equivalents were analyzed 
for all other tissues. The 10-fold difference in the amount of tissue 
equivalents loaded is accounted for by the split scale, where the 
result from 2-mg equivalents was multiplied by 10. Data shown are 
the average of 4 duplicate gels run for each sample. PrPres level 
in elk brain is signiﬁ  cantly different from deer brain (p<0.001), elk 
tonsil is signiﬁ  cantly different from deer tonsil (p = 0.0274), and elk 
RPLN is signiﬁ  cantly different from deer RPLN (p = 0.0087) (Mann-
Whitney test). C, reference control; U, uninfected elk or deer.
Figure 3. Representative immunoblot showing the relative amount 
of disease-associated prion protein (PrPres) in brain, tonsil, and 
selected lymph nodes from a single chronic wasting disease 
(CWD)–affected mule deer. All lanes were loaded with 10-mg 
equivalents of tissue (original wet weight basis). Lane 1, brain; 
lane 2, tonsil; lane 3, popliteal lymph node; lane 4, retropharyngeal 
lymph node (RPLN); lane 5, prescapular lymph node; lane 6, 
submandibular lymph node; lane 7, mesenteric lymph node. PrPres 
bands were visualized by using antibody L42 at 0.04 μg/mL and 
standard enhanced chemiluminescence processing.RESEARCH
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by using immunoblot analysis. For example, PrPres was 
detected at high levels in deer, but not in elk, when 20-mg 
equivalents of tonsil or RPLN were analyzed. In contrast, 
brains from these deer and elk were all highly positive when 
the same immunoblot method was used. Both the quantita-
tive PrPres difference (Figure 2) and the differences in the 
frequency of PrPres detection (Tables 1, 2) between elk 
brain and lymph nodes were not noted in previous stud-
ies in which nonquantitative ELISA or IHC methods were 
used (5,18,19). In these reports, most elk (85%–94%) had 
detectable PrPres in both brain and RPLN; however, 6%–
15% of the elk had no PrPres in RPLN when brain was 
positive, which was similar to our immunoblot results. In 
fact, RPLN from most of the elk in our study were also pos-
itive by ELISA or IHC (data not shown). Thus, ELISA and 
IHC appeared to be more sensitive than immunoblot for 
PrPres detection and therefore more appropriate methods 
for diagnosis and surveillance. In contrast, immunoblotting 
appeared to be more useful for studies requiring quantita-
tion or visualization of PrPres banding patterns.
Our results suggest that fundamental differences may 
exist in the pathogenesis of CWD between deer and elk. 
In CWD-infected deer, as with scrapie in sheep, infectivity 
and PrPres are detectable in lymphoid tissues early after 
infection, well before they can be detected in brain tissue 
(7,16). In deer and sheep, this early lymphoid involvement 
is considered important in the process of neuroinvasion and 
the kinetics of disease. After a period of replication in these 
peripheral sites, the infectious agent moves to the central 
nervous system. In elk, the low quantity of PrPres in ton-
sil or lymph nodes suggests that lymphoid infection may 
not necessarily precede neuroinvasion. Possibly the small 
amount of PrPres detected in elk tonsil and lymph node 
may actually originate from the brain. This situation may 
be similar to that of mink that have mink encephalopathy in 
which infection of peripheral lymphoid and other tissues is 
seen only when the animals are in the late stages of disease. 
It is unclear whether such spread from brain to the periph-
ery is bloodborne or mediated by retrograde transmission 
through autonomic nerves (31).
In the TSE diseases in which lymphoid tissues are sub-
stantially involved, i.e., sheep scrapie and CWD in deer, 
horizontal transmission in natural situations is efﬁ  cient. In 
contrast, when peripheral lymphoid tissues are not exten-
sively involved, i.e., BSE in cattle (14,15), and naturally 
occurring CWD in elk, horizontal transmission appears 
to be relatively inefﬁ  cient (Table 2). Thus, differences in 
lymph node PrPres levels correlate with differences in the 
prevalence of CWD in deer and elk in natural settings. This 
ﬁ  nding might be the result of greater quantities of CWD in-
fectivity released to the environment from lymphoid tissues 
of deer that have died or been killed. Also because there is 
widespread distribution of large quantities of PrPres in deer 
lymphoid tissues, it seems possible that infectivity might 
also be present in other peripheral tissues such as intestine, 
kidney, or salivary glands, which could possibly lead to ex-
cretion or secretion of infectivity in feces, urine, or saliva. 
One would also expect brain-associated infectivity to be a 
source of environmental contamination, and in this regard 
brain from CWD-infected elk represents as great a risk as 
CWD-infected brain from deer.
Several other factors might also inﬂ  uence transmission 
within deer and elk populations. For example, differences 
in social interaction, the size of typical homeland range, 
Figure 4. Immunoblot showing disease-associated prion protein 
from chronic wasting disease–affected elk brain or mule deer 
brain, tonsil, spleen, and retropharyngeal lymph node before and 
after treatment with PNGaseF. Alternating lanes show before and 
after treatment for each tissue. PNGaseF digestion was done as 
described in Materials and Methods. Ten-milligram equivalents 
of tissue were used for PNGase F–negative lanes, and 4-mg 
equivalents of tissue were used for PNGase F–positive lanes. The 
blot was developed as described in Figure 3. 
Table 2. Comparison of PrPres tissue distribution in TSE-affected ruminants*† 
Species (condition)  Brain Spleen Nodes Tonsil Natural transmission 
Elk (CWD)  10/10 2/10 5/10 4/9 Low 
Mule deer (CWD)  12/12 2/10 12/12 9/10 High
White-tailed deer (CWD)  3/3 1/3 3/3 2/3 High
Sheep‡ (scrapie)  8/8 7/8 6/8 Yes  High
Cattle (BSE)§  6/6 Neg Neg Neg No
*PrPres, disease-associated prion protein; TSE, transmissible spongiform encephalopathy; CWD, chronic wasting disease; BSE, bovine spongiform 
encephalopathy; Neg, negative. 
†Distribution of PrPres or infectivity in peripheral tissues of TSE affected ruminants was compared. Data for deer and elk were determined in the study 
presented here. Data for sheep are from an earlier publication (30) as are the data for cattle (14,15)
‡Data from (30). 
§Data from (14). Chronic Wasting Disease in Deer and Elk
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preferred habitat, population densities, and so forth. The 
relative contribution of the possible factors is not known.
Although CWD prevalence in elk is low in natural 
settings, it can be much higher in conﬁ  nement situations. 
What differences increase transmission when animals 
are conﬁ  ned is not known. Apparently, high PrPres lev-
els in lymphoid tissues are not essential for transmission 
in crowded conditions. However, at least 2 factors might 
have an additional impact on transmission in captive elk. 
First, restricting elk to small pastures, sheds, or corrals 
where infectious material has accumulated over time might 
facilitate increased transmission. Second, in conﬁ  ned set-
tings, animal-to-animal contact would increase. This might 
involve exchange of infectivity through saliva, which has 
been found to be infectious in deer (32) and might also be 
positive in elk, although this remains unproven.
Earlier studies have not shown any evidence for trans-
mission of CWD to humans (33–35). CWD has been trans-
mitted to cattle by intracerebral but not by oral inoculation 
(36), and no reports have found that co-pasturing of CWD-
infected deer or elk with cattle has resulted in transmission. 
Furthermore, in vitro assays designed to test the susceptibil-
ity of humans or cattle to CWD suggested a very low prob-
ability of transmission to humans (37). Sheep, however, 
are likely to be more susceptible to CWD. They have been 
infected by intracerebral inoculation (38), and at a molecu-
lar level, CWD PrPres was shown to convert sheep PrP to 
the disease-associated form with relatively high efﬁ  ciency 
(37). Thus, among livestock, sheep might be a possible 
target for CWD infection in appropriate situations such as 
co-pasturing. Also, a CWD agent from putatively infected 
sheep could have a host range not usually associated with 
CWD and might cross species barriers more readily than 
CWD from cervids. Thus, if CWD continues to expand in 
deer and elk populations, the possibility of transmission to 
noncervid species will require continued surveillance.
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